Chiusolo, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 11.276
AS - Asia 8.759
EU - Europa 8.386
SA - Sud America 1.712
AF - Africa 280
OC - Oceania 186
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.608
Nazione #
US - Stati Uniti d'America 10.895
SG - Singapore 3.897
DE - Germania 2.414
CN - Cina 2.166
IT - Italia 1.447
BR - Brasile 1.382
SE - Svezia 1.156
VN - Vietnam 814
FR - Francia 768
GB - Regno Unito 568
UA - Ucraina 408
IN - India 400
IE - Irlanda 333
FI - Finlandia 285
ID - Indonesia 277
JP - Giappone 218
CA - Canada 205
PL - Polonia 197
RU - Federazione Russa 187
AU - Australia 162
HK - Hong Kong 157
AR - Argentina 130
NL - Olanda 127
MX - Messico 119
TR - Turchia 118
BD - Bangladesh 104
KR - Corea 103
IQ - Iraq 94
AT - Austria 75
ES - Italia 73
SA - Arabia Saudita 59
ZA - Sudafrica 59
CI - Costa d'Avorio 55
BE - Belgio 53
EC - Ecuador 45
VE - Venezuela 38
PK - Pakistan 37
IR - Iran 35
CZ - Repubblica Ceca 34
UZ - Uzbekistan 34
CH - Svizzera 33
MA - Marocco 32
CL - Cile 29
EG - Egitto 29
CO - Colombia 28
RO - Romania 27
TH - Thailandia 25
DZ - Algeria 24
LT - Lituania 23
AE - Emirati Arabi Uniti 22
NZ - Nuova Zelanda 22
PH - Filippine 22
UY - Uruguay 22
IL - Israele 21
KE - Kenya 20
PY - Paraguay 20
HU - Ungheria 19
NP - Nepal 19
MY - Malesia 16
PT - Portogallo 16
JO - Giordania 15
BG - Bulgaria 14
RS - Serbia 13
AZ - Azerbaigian 12
GR - Grecia 12
LB - Libano 12
SK - Slovacchia (Repubblica Slovacca) 12
ET - Etiopia 11
NO - Norvegia 11
PE - Perù 11
TN - Tunisia 11
TW - Taiwan 11
HR - Croazia 10
KZ - Kazakistan 10
CR - Costa Rica 9
EE - Estonia 9
SN - Senegal 9
AL - Albania 8
AM - Armenia 8
BA - Bosnia-Erzegovina 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
JM - Giamaica 8
KG - Kirghizistan 8
LV - Lettonia 8
OM - Oman 8
QA - Qatar 8
TT - Trinidad e Tobago 7
GE - Georgia 6
MD - Moldavia 6
AO - Angola 5
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
BZ - Belize 5
PA - Panama 5
EU - Europa 4
HN - Honduras 4
IS - Islanda 4
PR - Porto Rico 4
Totale 30.534
Città #
Singapore 2.109
Chandler 1.057
Ashburn 1.010
San Jose 944
Beijing 421
Dublin 324
Los Angeles 316
Jacksonville 300
Hefei 296
Rome 270
Milan 264
Ho Chi Minh City 253
Dearborn 243
Jakarta 241
Lauterbourg 229
San Mateo 228
Hanoi 219
New York 214
Munich 204
Tokyo 196
Houston 192
Nanjing 179
Ann Arbor 169
Frankfurt am Main 168
Wilmington 165
Boston 154
Warsaw 154
Dallas 151
The Dalles 137
Hong Kong 135
Hyderabad 135
Chicago 129
São Paulo 121
Seattle 118
Council Bluffs 117
Woodbridge 117
Nürnberg 114
Fairfield 113
Moscow 112
Helsinki 107
Redwood City 106
Lancaster 97
Seoul 92
Buffalo 91
Cattolica 89
Nanchang 85
Marseille 84
Santa Clara 84
Kent 83
Princeton 83
Orem 76
Bremen 71
Lawrence 70
St Louis 66
Shanghai 63
London 60
Boardman 58
Florence 57
Abidjan 55
Nuremberg 54
Paris 54
Phoenix 53
Redmond 53
Izmir 51
Lappeenranta 51
Tianjin 50
Brussels 49
San Francisco 48
Toronto 48
Atlanta 47
Brooklyn 46
Denver 46
Guangzhou 46
Kunming 46
Rio de Janeiro 45
Chennai 43
Poplar 42
Da Nang 39
Amsterdam 37
Belo Horizonte 37
Montreal 36
Cambridge 35
Johannesburg 35
Sydney 35
Vienna 35
Mexico City 34
Stockholm 34
Turku 34
Philadelphia 33
Shenyang 33
Norwalk 32
Portland 32
Haiphong 31
Melbourne 31
Pune 31
Hangzhou 30
Tashkent 30
Baghdad 28
Düsseldorf 28
Leawood 28
Totale 15.225
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.280
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 380
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 373
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Correlation between paraproteinaemia and viral reactivation after allo-SCT 215
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 209
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 188
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 188
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 182
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 182
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 180
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 179
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 177
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 175
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 172
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 171
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 168
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Work related acute leukemia and mucor mycosis in a boat-builder 162
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 162
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Hyperleukocytosis and leukostasis: management of a medical emergency 159
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 157
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 157
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 156
Neurologic improvement after peripheral blood stem cell transplantation in poems 156
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 156
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 156
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 155
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 155
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 155
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 153
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 152
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 149
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 148
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 147
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 147
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Hyperleukocytosis and leukostasis: management of a medical emergency 146
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 145
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 143
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 140
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 140
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 135
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 135
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 133
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 132
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 131
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 131
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 130
Aggiornamenti di Diagnostica Molecolare in Ematologia 129
Red Blood Cell Exchange as a Valid Therapeutic Approach for Pregnancy Management in Sickle Cell Disease: Three Explicative Cases and Systematic Review of Literature 127
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 127
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 127
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 127
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 127
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 126
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 125
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 122
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 121
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 121
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 121
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes 120
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 120
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 120
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 117
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 116
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 116
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 115
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial 115
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 115
Changes in protein serum levels during stem cell transplantation 115
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
Totale 19.062
Categoria #
all - tutte 116.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 0 266 44
2021/20221.551 150 91 43 70 104 39 35 221 90 127 261 320
2022/20233.215 436 436 243 476 226 378 182 241 316 89 134 58
2023/20242.681 84 452 125 172 150 302 162 115 105 266 367 381
2024/20255.876 358 271 446 286 462 205 266 254 698 641 1.096 893
2025/202611.384 1.651 493 902 1.320 1.892 645 1.905 692 896 882 106 0
Totale 31.071